 |
Search Term: Gliosarcoma
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!
Trials and Noteworthy Treatments
|
|
|
|
|
|
Treatment Next 25
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
|
Boston, MA |
|
09/06/2009 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
|
Durham, NC |
|
09/05/2009 |
|
|
|
Details |
|
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
|
San Francisco, CA |
|
07/07/2009 |
|
|
|
|
|
Details |
|
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma |
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
Details |
|
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
|
Toronto, Ontario, CANADA
Bethesda, MD
New York, NY
Cincinnati,, OH
Columbus, OH |
|
04/21/2009 |
|
|
|
|
|
Details |
|
Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
04/14/2009 |
|
|
|
Details |
|
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
|
San Francisco, CA |
|
04/06/2009 |
|
|
|
|
|
Details |
|
Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
|
Houston, TX |
|
04/03/2009 |
|
|
|
Details |
|
A Phase II study of Bevacizumab (Avastin?) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
|
San Francisco, CA |
|
01/09/2009 |
|
|
|
|
|
Details |
|
NABTC05-02 - Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
|
San Francisco, CA |
|
01/09/2009 |
|
|
|
Details |
|
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
|
Santa Monica, CA |
|
11/29/2008 |
|
|
|
|
|
Details |
|
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
|
Houston, TX |
|
10/27/2008 |
|
|
|
Details |
|
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/27/2008 |
|
|
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
|
Boston, MA
New York, NY
Houston, TX
Charlottesville, VA |
|
10/09/2008 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Charlottesville, VA |
|
09/30/2008 |
|
|
|
|
|
Details |
|
Gliogene: An International Brain Tumor Study |
|
Houston, TX |
|
07/24/2008 |
|
|
|
Details |
|
Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
05/28/2008 |
|
|
|
|
|
Details |
|
Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma |
|
Houston, TX |
|
05/28/2008 |
|
|
|
Details |
|
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
News Stories
(Relevance) Question - click to see the response!
Displaying 1 to 1 of 1
(Relevance) Page Title - click title to go to the page!
Frequently Asked Questions
(Relevance) Question - click to see the response!
Displaying 1 to 1 of 1
(0.7967)
What is gliosarcoma? What are the typical symptoms, how it is diagnosed, how it is treated and how dangerous it is?
|
